Buscar en
Porto Biomedical Journal
Toda la web
Inicio Porto Biomedical Journal Role of platelets in immune system and inflammation
Journal Information
Vol. 2. Issue 6.
Pages 311-314 (November - December 2017)
Download PDF
More article options
Vol. 2. Issue 6.
Pages 311-314 (November - December 2017)
Open Access
Role of platelets in immune system and inflammation
Ozge Sonmeza,
Corresponding author

Corresponding author.
, Mehmet Sonmezb
a Istanbul University Cerrahpasa Medicine Faculty, English Medicine Programme, Istanbul, Turkey
b Karadeniz Technical University, School of Medicine, Department of Haematology, Trabzon, Turkey
This item has received

Under a Creative Commons license
Article information
Full Text
Download PDF
Tables (1)
Table 1. Roles of platelets in immune system.

Platelets have significant role in modulating clot formation. Additionally, emerging data indicates that platelets have considerable roles in inflammation and immune response. Platelets gather at the damaged cite and adhere to white blood cells. Subsequently, they release cytokines and chemokines which are chemotactic for neutrophils and monocytes. Therefore, platelets are necessary for targeting lymphocytes, neutrophils and monocytes to inflammation site. Those interactions enhance inflammation. Moreover, platelets serve as an immune cell by engulfing microbes. Presence of platelets affect prognosis in some bacterial or viral infection and several other diseases.

Immune system
Full Text

Platelets are anucleated discoid shape hematopoietic cells which have considerable roles in modulating hemostasis. Recent studies indicate that platelets are also involved in inflammation, infection, host response and even cancer. Platelets express and secrete adhesion molecules to accumulate in damaged sites. Adhesion molecules favor adhesion of platelets to leukocytes and granulocytes. Furthermore, platelets secrete immune modulators which are chemotactic for neutrophils, monocytes and lymphocytes. Those interaction results in formation of platelet-granulocyte or platelet-leukocyte aggregates which triggers further inflammation.1–3 Platelets are also involved in natural immunity because they can capture and engulf microbes. In addition; they prevent dissemination of bacteria by clot formation.3,4


Platelets are small fragments of megakaryocytes. There are 150–400.000 platelets per microliter of blood. Each of them contain three types of granules: alpha [chemokines such as: CXCL7, CXCL4 (PF4), CXCL1 (GROa), CXCL5, CCL5 (RANTES), CCL3 (MIP1a), coagulation factors, Platelet-derived growth factor receptors (PDGF), Transforming growth factor beta (TGF-b), P-selectin, fibrinogen, vWF, fibronectin,], dense (calcium, magnesium, nucleotides (ADP,ATP), serotonin, histamine) and lysosomal [gylcohydrolase, proteases (cathepsin, asid phospatase,colagenase, elastase)] granules.5 P-selectin is an α-granule derived mediator which facilitates rolling and tethering of leukocyte and adhesion of leukocytes to endothelium following to activation of platelets. Dense bodies induce vasoconstriction, production of pro-inflammatory cytokines and modulation of inflammation.6 Dense granules contains high amount of serotonin. Recent research reveals that recruitment of neutrophils is promoted by platelet derived serotonin in acute inflammation.7 Ions such as Ca and Mg probably effects signal transduction during all those interactions. Some enzymes (e.g. cathepsin) of lysosomal granules nonspecifically breakdown microbe so they are classified as first line defenders of immunity.3

Pro-inflammatory cytokines are released in inflammation and accepted as one of the key regulatory of inflammation. Those cytokines can be secreted from different cell types, have different targets and activate different pathways. Interleukin-1 (IL-1) is an important cytokine secreted mostly by monocytes and macrophages that stimulate acute phase reactants, fever and adhesion molecules. Evidence indicates that platelets secrete IL-1 as well.8 Activated platelets induce dendritic cells (DC) to release immunoregulatory cytokine IL-10.9 In addition; platelets can stimulate monocytes which in turn secrete Interleukin-8.10


Granules of thrombocytes contain chemokines produced by megakaryocytes. RANTES (regulated on activation, normal T cell expressed and secreted, also known as CCL5) is a CC chemokine family member. Monocytes tether to endothelium via P-selectin and this induce platelet derived RANTES release. Thereby, recruitment of further monocytes from circulation is triggered.10,11 Platelet derived RANTES has also immune-modulator affect. RANTES enhance cytotoxic ability of CD8 T-helper cells and cytokine production in CD8 T-cells.12 Furthermore, RANTES mRNA expression increases after platelet interacts with B-cells and IgG synthesis from differentiated B-cells is promoted13 CXC chemokines such as IL-8, neutrophil-activating peptide-2 (NAP-2) coordinates recruitment and activation of neutrophils.14,15 Beta-thromboglobulin (β-TG), platelet factor 4 (PF4) are also CXC class chemokines that are chemotactic for neutrophils. PF4 induces differentiation of monocyte to macrophages and augment monocyte survival.16 PF4 can directly kill intra erythrocytic parasites after contact with parasitized cells.17 Thus, platelets might be accepted as natural anti-parasitic. Moreover, platelet derived RANTES and PF4 augment surface monocyte arrest. As a summary, platelets are necessary for targeting lymphocytes, neutrophils and monocytes to inflammation site.A chemokine derived peptide; “Thrombocidin” which is antibacterial and antifungal is stored in α-granules Thus, platelets has an impact on innate immune system.18,19

Pattern recognition receptor

Membrane of a platelet is covered by a great number of receptors such as transmembrane, pattern recognition and FcR receptors that are stimulated by paracrine, exocrine and autocrine signaling. Toll like Receptors (TLR) are members of pattern recognition receptor family. Recent researches confirm that there is expression of TLR1, TLR2, TLR4, TLR6, TLR9, TLR7 and TLR9on platelets. They are activated upon interaction with a stimulator like viruses, microbes or other hematopoietic cells.20–24 Encephalomyocarditis virus (EMCV) activates the platelet-TLR7 receptor. Subsequently, thrombocytopenia is observed because platelet interacts with leukocytes and forms aggregates following to internalization of neutrophils. Therefore, platelets-TLR7 is important in host survival.20 TLR2 recognizes bacteria. Stimulation of TLR2 amplifies P-selectin expression, enhances pro-inflammatory response of platelet and increases formation of platelet-neutrophil aggregation.24 TLR4 enhances bacterial trapping by stimulating formation of neutrophil extracellular trapping (NETs).23 TLR4 activation by bacterial LPS causes formation of platelet-granulocyte aggregates.25 Platelets also present bacteria to neurophils via toll TLR.2

CLEC-2 (C-type lectin-like receptor) is a kind of ITAM receptor (also known as tyrosine kinase-dependent platelet activation receptor) which is expressed on T cells, platelets, DC and probably other hematopoietic cells. It is also expressed on platelets. Podoplanin (also known as Gp38) is potent ligand for celec-2 receptor and found in lymphatic endothelial cells. CLEC2-podoplanin interaction is important in separation of blood-lymphatic during embryogenesis, proliferation of lymphatic cells, development of lymph nodes, recruitment of lymphocyte in long-term. Briefly it influences development of tissues of immune system and immune response.26,27 On the other hand, CLEC-2 receptors of platelets bind podolomin expressing tumor cells which is considered as one of the metastasis mechanism.28

CD40L (also known as CD154 a member of TNF (Tumor Necrosis Factor) family) is found in platelets and its receptor is CD40 which is described on many cell types including B-cells and antigen presenting cells. CD40-CD40L interaction contributes to binding of platelets to monocytes, macrophages, DCs and lymphocytes. That interaction induce several immune and inflammatory response such as production of superoxide and reactive oxygen species (ROS) in neutrophils, production of antigen specific IgG, activation of B cells, switching of B cell isotype, priming of T cell, formation of germinal center, activation of macrophages, maturation of DC and enhancing cytotoxic T–cell response.1,13,29–32

Complement system induces platelets and vice versa. It has been known for a long time that complement system promotes thrombus formation by activating platelets. However, emerging studies indicates platelets also activate the complement system through P-selectin–C3B interaction.33 Platelets have also receptors for C1Q which has a role in classic pathway.34

Membrane glyocoproteins function as receptors so are involved in adhesion. Leukocyte recruitment after an injury depends on interaction of A mb2 (Mac-1) integrin of leukocytes and glycoprotein (GP) Ib-a of platelets.35

Platelets express high affinity IgE receptor (FcepsilonRI) on their cell membrane. Stimulation of FcepsilonRI receptor triggers release of serotonin and RANTES and subsequently promotes IgE mediated allergic reaction.36

Adhesion molecules

Adhesion molecules are secreted from α-granules of platelets and they are quite important in thrombus formation. As it is mentioned before, P-selectin is a type of adhesion molecule is secreted from α-granules. Main function of P-selectin is mediating rolling and tethering through adhesion. However, recent researches reveal the key stone role of P-selectin in platelet mediated inflamation. P selectin interacts with those expressing PSGL1 (P selectin glycol protein) such as neutrophils, monocytes, DC, endothelial cells and other activated platelets. P-selectin-PSGL1 interaction results in production of superoxide anion radicals in macrophages and monocytes, stimulation of neutrophil rolling, transendothelial migration and leukocytes integrin activation. Furthermore, cell adhesion via P-selectin regulates gene expression in leukocytes. Generation of dentritic like cells from monocytes by P-selectin stimulation is seen experimentally. As a result, DC might present antigens captured by platelets due to DC-platelet interaction through P-selectin. Ultimately, disturbing P-selectin-PSGL1 interaction reduces inflammation.2,37–43

Experimentally, activation of TLR7 agonist enhance p-selectin expression and stimulate platelets-white blood cells (WBC) interaction.20 Thus, we can conclude that adhesive molecules of platelets might be necessary to attract granulocytes to injured sites. Integrins are transmembrane receptors which have significant impact on platelet adhesion. Different subtypes of integrins are discovered in different cell types including hematopoetic cells (such as leukocyte and platelet), collagen and endothelial fibroblasts. β1, β2 and β3 integrins are expressed on platelets and mostly involved in adhesion of platelets to extracellular matrix and fibrinogen.44,45

ICAM-2 (intercellular adhesion molecule 2) is a member of Ig superfamily and the only ligand of β2 integrin presents on platelets. ICAM-2 of platelets contribute to adhesion and tethering of T cells via binding of leukocyte integrin; LFA1 (Leukocyte function antigen1).46 In short, leukocyte-platelet interaction requires integrins.

Role of platelet in certain diseases

Even the exact reason is still uncertain; in many viral infections non-immune thrombocytopenia is observed. Thrombocytopenia may be a sign of infection, due to the fact that platelets are recruited to the site of inflammation and adhere to WBC to enhance their affect and form aggregates so the number of circulating thrombocytes decreases. Platelets could be related to prognosis of viral infection. Furthermore, platelet is a SOFA (Sequential Organ Failure Assessment) parameter which is used in sepsis evaluation.47 Coxsackie virus B is a picornoviridia family member and it carries linear positive sense ssRNA. It is the most common cause of myocarditis. If platelets are depleted, the risk of myocarditis development increases.48 Dengue virus is positive-stranded RNA virus of the flaviviridae family and transmitted through mosquitoes. It causes dengue fever. Thrombocytopenia is seen due to mitochondrial dysfunction and apoptotic caspase stimulation in case of Dengue virus infection.49 EMCV infection may cause TLR-7 mediated thrombocytopenia, probably due to formation of platelet-leukocyte aggregates and more importantly presence of platelet TLR7 increases survival during infection in mices.20 Human immunodeficiency virus (HIV) is retrovirus which may causes acquired immunodeficiency syndrome (AIDS). It is demonstrated that platelets can engulf HIV virus.4 However, consequences of this engulfment are contradictory. Virus engulfment might hide virus from further immune reactions or it may prevent dissemination of virus. Experimental autoimmune encephalomyelitis is mouse model of Multiple Sclerosis (MS). Myelin sheath destruction, inflammation and lesion formation are main characteristics. In a study on experimental autoimmune encephalomyelitis, platelets were shown to promote CNS inflammation.50

Platelets are engaged in bacterial infection as well. Platelet can directly engulf bacteria namely Staphylococcus aureus which is responsible from mild to life threatening infections including skin infections, pneumonia, endocarditis and osteomyelitis.4 Bacterial engulfment by platelets might be accepted as first line defense mechanism of the immune system. Bacterial lipopolysaccharides (LPS) are outer surface membrane of gram-negative bacteria and affect immune response of human to bacteria. LPS stimulates secretion of α and dense granules and expression of P-selectin on platelets through TLR4 signaling pathway. TREM1 is a member of Ig superfamily expressed by myeloid cells. A ligand for TREM-1(triggering receptor expressed on myeloid cells) has recently found in platelets. TREM-1 ligand activates neutrophils in presence of LPS.25,51 On the other hand, platelets may cause dissemination of bacteria for example; Streptococcus pyogenes binds to the platelets and so bacteria spread.52

Neurophil extracellular trap formation (NET)

Neutrophils play a role in resistance to pathogens mainly via three mechanisms: antimicrobial cytokine secretion, engulfment and NET formation.53 Following to administration of virus such as Poxvirus or bacteria, platelets adhere to surface of neutrophils and extracellular fiber matrix called NET is released.23,54 NET formation is induced by activation of platelet TLR4 in severely septic human plasma.23 In another study; inhibition of activated platelets reduces NET formation in vivo experiment of transfusion-related acute lung injury (TRALI).55

Aggregate formation

Chronic or continued interaction of platelets with endothelial cells or WBCs can cause excessive immune stimulation or complex accumulation.3 Excessive platelet-monocyte complex accumulation might be a finding of vascular diseases, for instance: Elevated level of monocyte-platelet aggregates are accepted as early hallmark of MI acute myocardial infarction (AMI).51,56 Furthermore, circulating platelet–leukocyte aggregates (PLAs) might be a marker of sepsis.57 Additionally, aggregate formation may lead to atherosclerosis and platelets may facilitate it because α-granules contain pro-angiogenic proteins.5,58


To conclude, platelets are involved in immune response by direct and indirect mechanisms and have many significant roles in fighting infection (Table 1). Multiple interactions between platelets and other immune cells, expressing immune receptors, secreting immune mediator indicates the roles of platelets in immune system and inflammation. Furthermore, functional platelet activation might increase therapy response in situation of inflammation or infection. However, if platelets are activated continuously or chronically, this may cause different uncontrolled diseases notably vascular diseases especially atherosclerosis.

Table 1.

Roles of platelets in immune system.

Secretion of chemotactic chemokines and granules for WBC 
NET formation 
Blocking of spread of infection by clot formation 
Induction of pro-inflammatory cytokines 
Breakdown of microbes by lysosomal granules 
Stimulation of recruitment of WBC to inflammation site 
Engulfing bacteria 
Secreting chemokine which are antifungal and antibacterial 
Conflicts of interest

The authors declare no conflicts of interest.

B.D. Elzey, J. Tian, R.J. Jensen, A.K. Swanson, J.R. Lees, S.R. Lentz, et al.
Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments.
Immunity, 19 (2003), pp. 9-19
J.W. Semple, J.E. Italiano Jr., J. Freedman.
Platelets and the immune continuum.
Nat Rev Immunol, 11 (2011), pp. 264-274
C.N. Morrell, A.A. Aggrey, L.M. Chapman, K.L. Modjeski.
Emerging roles for platelets as immune and inflammatory cells.
Blood, 123 (2014), pp. 2759-2767
T. Youssefian, A. Drouin, J.M. Massé, J. Guichard, E.M. Cramer.
Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation.
Blood, 99 (2002), pp. 4021-4029
S.P. Watson, N.V. Morgan, P. Harrison.
The vascular function of platelets.
Post-graduate Hematology. Oxford, UK,
C.N. Jenne, R. Urrutia, P. Kubes.
Platelets: bridging hemostasis, inflammation, and immunity.
Int J Lab Hematol, 35 (2013), pp. 254-261
D. Duerschmied, G. Suidan, M. Demers, N. Herr, C. Carbo, A. Brill, et al.
Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice.
Blood, 121 (2013), pp. 1008-1015
X. Wang, Y. Luo, P.P. Masci, R. Crawford, Y. Xiao.
Influence of interleukin-1 beta on platelet-poor plasma clot formation: a potential impact on early bone healing.
PLOS ONE, 11 (2016), pp. e0149775
K. Kissel, S. Berber, A. Nockher, S. Santoso, G. Bein, H. Hackstein.
Human platelets target dendritic cell differentiation and production of proinflammatory cytokines.
Transfusion, 46 (2006), pp. 818-827
A.S. Weyrich, M.R. Elstad, R.P. McEver, T.M. McIntyre, K.L. Moore, J.H. Morrissey, et al.
Activated platelets signal chemokine synthesis by human monocytes.
J Clin Invest, 97 (1996), pp. 1525-1534
P. von Hundelshausen, K.S. Weber, Y. Huo, A.E. Proudfoot, P.J. Nelson, K. Ley, et al.
RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.
Circulation, 103 (2001), pp. 1772-1777
A. Crawford, J.M. Angelosanto, K.L. Nadwodny, S.D. Blackburn, E.J. Wherry.
A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection.
PLoS Pathog, 7 (2011), pp. e1002098
F. Cognasse, H. Hamzeh-Cognasse, S. Lafarge, P. Chavarin, M. Cogné, Y. Richard, et al.
Human platelets can activate peripheral blood B cells and increase production of immunoglobulins.
Exp Hematol, 35 (2007), pp. 1376-1387
A. Ludwig, F. Petersen, S. Zahn, O. Götze, J.M. Schröder, H.D. Flad, et al.
The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2.
Blood, 90 (1997), pp. 4588-4597
M. Baggiolini, B. Dewald, B. Moser.
Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines.
Adv Immunol, 55 (1994), pp. 97-179
B. Scheuerer, M. Ernst, I. Dürrbaum-Landmann, J. Fleischer, E. Grage-Griebenow, E. Brandt, et al.
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages.
Blood, 95 (2000), pp. 1158-1166
B.J. McMorran, L. Wieczorski, K.E. Drysdale, H.M. Huang, C. Smith, C. Mitiku, et al.
Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum.
Science, 338 (2012), pp. 1348-1351
J. Krijgsveld, S.A. Zaat, J. Meeldijk, P.A. van Veelen, G. Fang, B. Poolman, et al.
Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines.
J Biol Chem, 275 (2000), pp. 20374-20381
P.H. Kwakman, J. Krijgsveld, L. de Boer, L.T. Nguyen, L. Boszhard, J. Vreede, et al.
Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.
J Biol Chem, 286 (2011), pp. 43506-43514
M. Koupenova, O. Vitseva, C.R. MacKay, L.M. Beaulieu, E.J. Benjamin, E. Mick, et al.
Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.
R. Shiraki, N. Inoue, S. Kawasaki, A. Takei, M. Kadotani, Y. Ohnishi, et al.
Expression of Toll-like receptors on human platelets.
Thromb Res, 113 (2004), pp. 379-385
F. Cognasse, H. Hamzeh, P. Chavarin, S. Acquart, C. Genin, O. Garraud, et al.
Evidence of Toll-like receptor molecules on human platelets.
Immunol Cell Biol, 83 (2005), pp. 196-198
S.R. Clark, A.C. Ma, S.A. Tavener, B. McDonald, Z. Goodarzi, M.M. Kelly, et al.
Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood.
Nat Med, 13 (2007), pp. 463-469
P. Blair, S. Rex, O. Vitseva, L. Beaulieu, K. Tanriverdi, S. Chakrabarti, et al.
Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase.
Circ Res, 104 (2009), pp. 346-354
G. Zhang, J. Han, E. Welch, R.D. Ye, T.A. Voyno-Yasenetskaya, A.B. Malik, et al.
LPS stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.
J Immunol, 182 (2009), pp. 7997-8004
C. Bénézech, S. Nayar, B. Finney, D.R. Withers, K. Lowe, G.E. Desanti, et al.
CLEC-2 is required for development and maintenance of lymph nodes.
Blood, 123 (2014), pp. 3200-3207
M. Osada, O. Inoue, G. Ding, T. Shirai, H. Ichise, K. Hirayama, et al.
Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells.
J Biol Chem, 287 (2012), pp. 22241-22252
Y. Chang, P. Hsieh, Y. Chang, M.H. Lu, T.F. Huang, K.Y. Chong, et al.
Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis.
Oncotarget, 6 (2015), pp. 42733-42748
P. Vanichakarn, P. Blair, C. Wu, J.E. Freedman, S. Chakrabarti.
Neutrophil CD40 enhances platelet-mediated inflammation.
Thromb Res, 122 (2008), pp. 346-358
R. Elgueta, M. Benson, V. Vries, A. Wasiuk, Y. Guo, R. Noelle.
Molecular mechanism and function of CD40/CD40L engagement in the immune system.
Author manuscript; available in PMC 2013 November 13
B.D. Elzey, J.F. Grant, H.W. Sinn, B. Nieswandt, T.J. Waldschmidt, T.L. Ratliff.
Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation.
J Leukoc Biol, 78 (2005), pp. 80-84
B.D. Elzey, N.W. Schmidt, S.A. Crist, et al.
Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge.
Blood, 111 (2008), pp. 3684-3691
I. Conde, M. Crúz, H. Zhang, J. López, V. Afshar-Kharghan.
Platelet activation leads to activation and propagation of the complement system.
J Exp Med, 201 (2005), pp. 871-879
C. Skoglund, J. Wetterö, P. Tengvall, T. Bengtsson.
C1q induces a rapid up-regulation of P-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets.
Immunobiology, 215 (2010), pp. 987-995
A.C. Zago, D.I. Simon, Y. Wang, M. Sakuma, Z. Chen, K. Croce, et al.
The importance of the interaction between leukocyte integrin Mac-1 and platelet glycoprotein Ib-a for leukocyte recruitment by platelets and for the inflammatory response to vascular injury.
Arq Bras Cardiol, 90 (2008), pp. 54-63
S. Hasegawa, R. Pawankar, K. Suzuki, T. Nakahata, S. Furukawa, K. Okumura, et al.
Functional expression of the high affinity receptor for IgE (FcepsilonRI) in human platelets and its’ intracellular expression in human megakaryocytes.
Blood, 93 (1999), pp. 2543-2545
T. Mahoney, A. Weyrich, D. Dixon, T. McIntyre, S. Prescott, G. Zimmerman.
Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes.
Proc Natl Acad Sci U S A, 98 (2001), pp. 10284-10289
P.S. Frenette, C.V. Denis, L. Weiss, K. Jurk, S. Subbarao, B. Kehrel, et al.
P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo.
J Exp Med, 191 (2000), pp. 1413-1422
Z. Laszik, P.J. Jansen, R.D. Cummings, T.F. Tedder, R.P. McEver, K.L. Moore.
P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells.
Blood, 88 (1996), pp. 3010-3021
T. Xu, L. Zhang, Z. Geng, H. Wang, J. Wang, M. Chen, et al.
P-Selectin cross-links PSGL-1 and enhances neutrophil adhesion to fibrinogen and ICAM-1 in a Src kinase-dependent, but GPCR-independent mechanism.
Cell Adh Migr, 1 (2007), pp. 115-123
G. Li, Y.J. Kim, C. Mantel, H.E. Broxmeyer.
P-selectin enhances generation of CD14+CD16+ dendritic-like cells and inhibits macrophage maturation from human peripheral blood monocytes.
J Immunol, 171 (2003), pp. 669-677
T. Tsuji, K. Nagata, J. Koike, N. Todoroki, T. Irimura.
Induction of superoxide anion production from monocytes an neutrophils by activated platelets through the P-selectin-sialyl Lewis X interaction.
J Leukoc Biol, 56 (1994), pp. 583-587
Ü. Özgen, E. Özerol, M. Aminci.
Relationship between activation and apoptosis in platelets.
Turk J Haematol, 24 (2007), pp. 171-176
J.S. Bennett, B.W. Berger, P.C. Billings.
The structure and function of platelet integrins.
J Thromb Haemost, 7 (2009), pp. 200-205
C.L. Abram, C.A. Lowell.
The ins and outs of leukocyte integrin signaling.
Annu Rev Immunol, 27 (2009), pp. 339-362
Note: available in PMC 2011 Dec 29.
T.G. Diacovo, A.R. deFougerolles, D.F. Bainton, T.A.J. Springer.
ClinA functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2.
Invest, 94 (1994), pp. 1243-1251
C.W. Seymour, V.X. Liu, T.J. Iwashyna, et al.
Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3).
JAMA, 315 (2016), pp. 762-774
S. Negrotto, C. Jaquenod de Giusti, L. Rivadeneyra, A.E. Ure, H.A. Mena, M. Schattner, et al.
Platelets interact with Coxsackie viruses B and have a critical role in the pathogenesis of virus-induced myocarditis.
J Thromb Haemost, 13 (2015), pp. 271-282
E.D. Hottz, M.F. Oliveira, P.C. Nunes, R.M. Nogueira, R. Valls-de-Souza, A.T. Da Poian, et al.
Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases.
J Thromb Haemost, 11 (2013), pp. 951-962
H. Langer, E. Choi, H. Zhou, R. Schleicher, K.J. Chung, Z. Tang, et al.
Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
Circ Res, 110 (2012), pp. 1202-1210
P. Haselmayer, L. Grosse-Hovest, P. von Landenberg, H. Schild, M.P. Radsak.
TREM-1 ligand expression on platelets enhances neutrophil activation.
Blood, 110 (2007), pp. 1029-1035
F. Kahn, S. Hurley, O. Shannon.
Platelets promote bacterial dissemination in a mouse model of streptococcal sepsis.
Microbes Infect, 15 (2013), pp. 669-676
T. Mayadas, X. Cullere, C. Lowell.
The multifaceted functions of neutrophils.
Annu Rev Pathol, 9 (2015), pp. 181-218
Author manuscript; available in PMC 2015 January 1
C.N. Jenne, C.H. Wong, F.J. Zemp, B. McDonald, M.M. Rahman, P.A. Forsyth, et al.
Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps.
Cell Host Microbe, 13 (2013), pp. 169-180
A. Caudrillier, K. Kessenbrock, B.M. Gilliss, J.X. Nguyen, M.B. Marques, M. Monestier, et al.
Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury.
J Clin Invest, 122 (2012), pp. 2661-2671
M.I. Furman, M.R. Barnard, L.A. Krueger, M.L. Fox, E.A. Shilale, D.M. Lessard, et al.
Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction.
J Am Coll Cardiol, 38 (2001), pp. 1002-1006
H. Ogura, T. Kawasaki, H. Tanaka, T. Koh, R. Tanaka, Y. Ozeki, et al.
Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis.
J Trauma, 50 (2001), pp. 801-809
P. Blair, R. Flaumenhaft.
Platelet alpha-granules: basic biology and clinical correlates.
Blood Rev, 23 (2009), pp. 177-189
Copyright © 2017. PBJ-Associação Porto Biomedical/Porto Biomedical Society
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos